Attitudes and behavior of peripheral arterial disease patients toward influencing their physician’s prescription of cholesterol-lowering medication

Abstract

Among 355 peripheral arterial disease (PAD) patients with low density lipoprotein cholesterol (LDL-C) levels ≥ 70 mg/dl, we assessed knowledge regarding optimal LDL levels and the importance of LDL-C-lowering therapy. We also assessed PAD participants’ behaviors and attitudes regarding their engagement with their physician in treatment decisions for LDL-C lowering. The average baseline LDL-C level of participants was 103.4 mg/dl ± 30.7 mg/dl. Seventy-six percent of participants were taking at least one cholesterol-lowering medication. Sixty-six percent were unable to define their optimal LDL-C. Only 47% strongly agreed that their own actions and decisions could reduce their LDL-C. Just 29.8% were aware that patients who request specific medications from their physician were more likely to receive them, and 16% had asked their physician whether they should be taking more cholesterol-lowering medication. These findings suggest that further study is needed to identify effective interventions to educate PAD patients and their physicians about the importance of cholesterol-lowering therapy and to encourage PAD patients to participate with their physician in decisions regarding cholesterol-lowering treatment. Clinical Trial Registration - URL: http://www.clinicaltrials.gov. Unique identifier: NCT00217919

Keywords

atherosclerosis cholesterol intermittent claudication peripheral vascular disease

References

Heald CL , Fowkes FG , Murray GD , Price JF Ankle brachial index collaboration. Atherosclerosis 2006; 189: 61-69.

Ankle Brachial Index Collaboration. Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis. JAMA 2008; 300: 197-208.

CAPRIE Steering Committee. A randomized, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 1996; 348: 1329-1339.

Collins R. , Armitage J. , Parish S. , Sleight P. , Peto R. for the Heart Protection Study Collaborative Group. Effects of cholesterol-lowering therapy with simvastatin on stroke and other major vascular events in 20,536 people with cerebrovascular disease or other high risk condition. Lancet 2004; 363: 757-767.

Waters DP , Broton SC , Chiang CW , et al. Lipid Treatment Assessment Project 2: a multinational survey to evaluate the proportion of patients achieving low density lipoprotein cholesterol goals. Circulation 2009; 120: 28-34.

McDermott MM , Mehta S. , Ahn H. , Greenland P. Atherosclerotic risk factors are less intensively treated in patients with peripheral arterial disease than in patients with coronary artery disease. J Gen Intern Med 1997; 12: 209-215.

McDermott MM , Hahn EA , Greenland P. , et al. Atherosclerotic risk factor reduction in peripheral arterial disease: results of a national physician survey. J Gen Intern Med 2002; 17: 895-904.

Selvin E. , Hirsch AT Contemporary risk factor control and walking dysfunction in individuals with peripheral arterial disease: NHANES 1999-2004. Atherosclerosis 2008; 201: 425-433.

McDermott MM , Mandapat AL , Moates A. , et al. Knowledge and attitudes regarding cardiovascular disease risk and prevention in patients with coronary or peripheral arterial disease. Arch Intern Med 2003; 163: 2157-2162.

10.

Hollon MF Direct-to-Consumer marketing of prescription drugs. Creating consumer demand . JAMA 1999; 281: 382-384.

11.

Hamm RM , Hicks RJ , Bemben DA

Antibiotics and respiratory infections: are patients more satisfied when expectations are met?

J Fam Pract 1996; 43: 56-62.

12.

Groeneveld Fpmj , Bareman FP , Barentsen R. , Dokter HJ , Drogendijk AC , Hoes AW Determinants of first prescription of hormone replacement therapy. A follow-up study among 1689 women aged 45-60 years. Maturitas 1994; 20: 81-89.

13.

Grundy SM , Cleeman JI , Merz CN , et al. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 2004; 44: 720-723.

14.

Maly RC , Frank JC , Marshall GN , DiMatteo MR , Reuben DB Perceived efficacy in patient-physician interactions (PEPPI): validation of an instrument in older persons. J Am Geriatr Soc 1998; 46: 889-894.

15.

Hibbard JH , Stockard J. , Mahoney ER , Tusler M. Development of the patient activation measure (PAM): conceptualizing and measuring activation in patients and consumers. Health Services Research 2004; 39: 1005-1025.

16.

Svarstad BL , Chewning BA , Sleath BL , Claesson C. The brief medication questionnaire: a tool for screening patient adherence and barriers to adherence. Patient Educ Couns 1999; 37: 113-124.

17.

McDermott MM , Ades P. , Guralnik JM , et al. Treadmill exercise and resistance training in patients with peripheral arterial disease with and without intermittent claudication: a randomized controlled trial. JAMA 2009; 301: 165-174.

18.

Hirsch AT , Criqui MH , Treat-Jacobson D. , et al. The PARTNERS program: a national survey of peripheral arterial disease detection, awareness, and treatment. JAMA 2001; 286: 1317-1324.

19.

Vale MJ , Jelinek MV , Best JD , et al., for the COACH Study Group. Coaching patients on achieving cardiovascular health (COACH). Arch Intern Med 2003; 163: 2775-2783.

20.

Garber MC , Nau DP , Erickson SR , Aikens JE , Lawrence JB The concordance of self-report with other measures of medication adherence: a summary of the literature. Med Care 2004 ; 42: 649-652.

21.

Davis DA , Thomson MA , Oxman AD , Haynes RB Changing physician performance. A systematic review of the effect of continuing medical education strategies. JAMA 1995; 274: 700-705.

22.

Davis D. , O’Brian MA , Freemantle N. , Wolf FM , Mazmanian P. , Taylor-Vaisey A.

Impact of formal continuing medical education: do conferences, workshops, rounds, and other traditional continuing education activities change physician behavior or health care outcomes?

JAMA 1999 ; 282: 867-874.

23.

Rosenstock IM Why people use health services. Milbank Mem Fund Q 1966; 44: 94-127.

24.

Becker MH , Maiman LA Sociobehavioral determinants of compliance with health and medical care recommendations . Med Care 1975; 1: 10-24.

25.

Lichtman JH , Amatruda J. , Yaari S. , et al. Clinical trial of an educational intervention to achieve recommended cholesterol levels in patients with coronary artery disease. Am Heart J 2004; 147: 522-528.